DK48882A - Cystein-forbindelse og fremgangsmaade til dens fremstilling samt anvendelse af den - Google Patents

Cystein-forbindelse og fremgangsmaade til dens fremstilling samt anvendelse af den

Info

Publication number
DK48882A
DK48882A DK48882A DK48882A DK48882A DK 48882 A DK48882 A DK 48882A DK 48882 A DK48882 A DK 48882A DK 48882 A DK48882 A DK 48882A DK 48882 A DK48882 A DK 48882A
Authority
DK
Denmark
Prior art keywords
cystein
procedure
manufacturing
connection
oxothiazolidine
Prior art date
Application number
DK48882A
Other languages
English (en)
Inventor
A Meister
J W Williamson
Original Assignee
Cornell Res Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell Res Foundation Inc filed Critical Cornell Res Foundation Inc
Publication of DK48882A publication Critical patent/DK48882A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/04—Alpha- or beta- amino acids
    • C12P13/12—Methionine; Cysteine; Cystine

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Threshing Machine Elements (AREA)
  • Feed For Specific Animals (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK48882A 1981-02-11 1982-02-05 Cystein-forbindelse og fremgangsmaade til dens fremstilling samt anvendelse af den DK48882A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/233,564 US4335210A (en) 1981-02-11 1981-02-11 Method of producing L-cysteine

Publications (1)

Publication Number Publication Date
DK48882A true DK48882A (da) 1982-08-12

Family

ID=22877749

Family Applications (1)

Application Number Title Priority Date Filing Date
DK48882A DK48882A (da) 1981-02-11 1982-02-05 Cystein-forbindelse og fremgangsmaade til dens fremstilling samt anvendelse af den

Country Status (8)

Country Link
US (1) US4335210A (da)
EP (1) EP0057942B1 (da)
JP (1) JPS57188513A (da)
AT (1) ATE15445T1 (da)
CA (1) CA1167766A (da)
DE (1) DE3266087D1 (da)
DK (1) DK48882A (da)
NO (1) NO820399L (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4647571A (en) * 1981-02-11 1987-03-03 Cornell Research Foundation Cysteine delivery composition
CH654302A5 (de) * 1983-05-04 1986-02-14 Sandoz Ag Acylaminophenolderivate, ihre herstellung und arzneimittel, welche sie enthalten.
US4868114A (en) * 1987-08-05 1989-09-19 Regents Of The University Of Minnesota Method for elevating glutathione levels
JPH02202818A (ja) * 1988-12-09 1990-08-10 Allergan Inc 白内障の治療における２―置換―チアゾリジン―４―カルボン酸類の用途
CA1339070C (en) * 1989-01-26 1997-07-29 Wulf Droge Treatment of diseases associated with cysteine deficiency
US5580577A (en) * 1990-01-11 1996-12-03 Herzenberg; Leonard A. Method of treating the symptoms of human rhinovirus infection
JP2769243B2 (ja) * 1990-02-19 1998-06-25 ノボ ノルディスク アクティーゼルスカブ 溶液、特に発酵溶液から精製ｅｐｉ蛋白質の回収方法
EP0494405B2 (en) * 1991-01-10 2000-04-19 Transcend Therapeutics, Inc. Use of L-2-oxo thiazolidine-4-carboxylate for the treatment of pulmonary diseases
US5747459A (en) * 1991-02-04 1998-05-05 Nestec, Ltd. Method for insuring adequate intracellular glutathione in tissue
ATE137968T1 (de) * 1991-09-30 1996-06-15 Transcend Therapeutics Inc Verwendung von l-2-oxothiazolidine-4-carboxylate zur herstellung eines arzneimittels zur behandlung von latenten hiv-infektionen
AU661379B2 (en) * 1992-04-23 1995-07-20 Transcend Therapeutics, Inc Method of reducing or preventing toxicity associated with antiretroviral therapy
US5430045A (en) * 1992-04-23 1995-07-04 Free Radical Sciences, Inc. Method of reducing or preventing bone marrow hypoplasia
US5208249A (en) * 1992-08-20 1993-05-04 Clintec Nutrition Co. Method for stimulating intracellular synthesis of glutathione using esters of L-2-oxothiazolidine-4-carboxylate
US5589464A (en) * 1992-09-01 1996-12-31 Allergan Use of 2-substituted-thiazolidine-4-carboxylic acids for treatment of cataract
AU5040493A (en) 1992-11-30 1994-06-09 Transcend Therapeutics, Inc Method for treating systemic inflammatory response syndrome
US5447712A (en) * 1993-12-09 1995-09-05 Free Radical Sciences Method of reducing cyclophosphamide induced hemorrhagic cystitis
FR2742658B1 (fr) * 1995-12-22 1998-01-30 Oreal Utilisation de la procysteine comme agent depigmentant
US5780489A (en) * 1996-08-21 1998-07-14 Brooks; Benjamin Rix Method for treating amyotrophic lateral sclerosis
DE19711053C2 (de) * 1997-03-03 1999-09-02 Rommelspacher Kombinationspräparat aus 2-Methyl-thiazolidin-2,4-dicarbonsäure und Paracetamol
AU6676100A (en) 1999-08-17 2001-03-13 University Of Saskatchewan Technologies Inc. Improved treatment for acute physical insult to the central nervous system
US6864242B2 (en) * 2001-03-05 2005-03-08 Stephen P. Ernest Enteral formulation
US20060105972A1 (en) 2004-11-17 2006-05-18 Nagasawa Herbert T Method to enhance delivery of glutathione and ATP levels in cells
TW201201712A (en) * 2010-01-28 2012-01-16 Max International Llc Compositions comprising sugar-cysteine products
TW201202209A (en) * 2010-01-28 2012-01-16 Max International Llc Methods of preparing thiazolidines
US10239847B1 (en) 2016-03-03 2019-03-26 Cellactin Method for 2-oxothiazolidine-4-carboxylic acid for cellular glutathione

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2034536A1 (en) * 1969-02-11 1970-12-11 Academia Republ Roman A Thiazolidinecarboxylic acid-4derivs
US3974031A (en) * 1974-05-09 1976-08-10 Mitsubishi Chemical Industries Ltd. Process for producing L-cysteine or its derivatives
US4006057A (en) * 1974-11-06 1977-02-01 Ajinomoto Co., Inc. Method of producing L-cysteine and L-cystine
JPS5272883A (en) * 1975-12-12 1977-06-17 Ajinomoto Co Inc Preparation of sulfur-containing amino acid
US4384001A (en) * 1978-12-21 1983-05-17 Gosalvez Mario Treatment of tumors with thiazolidine-4-carboxylic acid

Also Published As

Publication number Publication date
US4335210A (en) 1982-06-15
NO820399L (no) 1982-08-12
EP0057942A2 (en) 1982-08-18
ATE15445T1 (de) 1985-09-15
DE3266087D1 (en) 1985-10-17
JPS57188513A (en) 1982-11-19
EP0057942B1 (en) 1985-09-11
CA1167766A (en) 1984-05-22
EP0057942A3 (en) 1982-10-27

Similar Documents

Publication Publication Date Title
DK48882A (da) Cystein-forbindelse og fremgangsmaade til dens fremstilling samt anvendelse af den
DK0454898T3 (da) Glycosaminoglycan-modificeret protein, fremgangsmåde til fremstilling af proteinet, farmaceutiske præparater indeholdende proteinet samt anvendelse af proteinet
ES2045131T3 (es) Solucion acuosa estable de trombina.
ES2109336T3 (es) Expresion de pace en celulas huesped y metodos de utilizacion de la misma.
FI883082A (fi) Konstruering av syntetisk dna och dess anvaendning i syntes av stora polypeptider.
ATA86885A (de) Verfahren zur herstellung lagerstabiler, schnellzerfallender pharmazeutischer wirkstoff-presslinge
ES2181689T3 (es) Variantes del factor de crecimiento de hepatocitos.
ATE247708T1 (de) Verfahren zur regulierung der metabolischen stabilität von proteinen
DE69534467D1 (de) Modifikation des starke-gehalts in pflanzen
DE69030765D1 (de) Medien zur zellzucht und verfahren dazu
GR3006172T3 (da)
DK222688D0 (da) Vaesker til konditionering af tand- og knoglestoffer, deres fremstilling og anvendelse
KR960016886A (ko) 수용성 비타민b를 함유하는 비경구 총 영양 용액
ES449707A1 (es) Un procedimiento para el acondicionamiento alcalino o neutrodel colageno para extraccion de gelatina.
DE68916754D1 (de) Verfahren zur Herstellung von optisch aktiver 3-Hydroxybuttersäure.
DK1200561T3 (da) Rekombinant stabil celleklon, dens fremstilling og anvendelse
DK462488A (da) Acylaminosyreracemase, fremstilling og anvendelse deraf
ES2004099A6 (es) Procedimiento de preparacion de polipeptidos biologicamente activos
SE7904161L (sv) Komposition for minskning av fenylalaninnivan i blod och anvendning derav
DE3864512D1 (de) Verfahren zur herstellung von kandis mit gepressten gaszellen.
EP0275901A3 (en) Gamma-glutamyl transpeptidase, its production and its use
NO861142L (no) Ekspresjon i e.coli av hybridpolypeptider som inneholder aminosyresekvenser til veksthormon-frigjoerende faktor.
DE3783145D1 (de) Rekombinantes dns-plasmid zur herstellung von xanthangummi.
SE7901917L (sv) Kemiskt forfarande
DK710588D0 (da) Enzym samt fremgangsmaade til enzymatisk hydrolyse af alfa-aminoadipinyl-monoaminoforbindelser

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment